We have initiated clinical selective screening for
inborn errors of metabolism in China by analysing
amino acids and acylcarnitines in a dried blood filter-paper samples using tandem mass spectrometry. Samples from a total of 3070 children suspected of
inborn errors of metabolism were collected through a study network which covered most provinces of China. The diagnoses were further confirmed through clinical symptoms, by gas chromatography-mass spectrometry and other biochemistry studies, and in a few cases by
DNA analysis. In all, 212 cases were diagnosed (6.6%) including 92 (43.4%) with
amino acids disorders (48 with
phenylketonuria, 12 with
ornithine carbamoyltransferase deficiency, 7 with tyrosinaemia type I, 9 with
maple syrup urine disease, 5 with citrullinaemia type I, 8 with citrullinaemia type II, 2 with
homocystinuria, and 1 with argininaemia); 107 (50.5%) with organic
acid disorders (including 58 with methylmalonic acidaemia, 13 with propionic acidaemia, 6 with isovaleric acidaemia, 7 with glutaric acidaemia type I, 6 with
3-methylcrotonyl-CoA carboxylase deficiency, 2 with 3-hydroxy-3-methylglutaryl-
CoA lyase deficiency, 10 with
multiple carboxylase deficiency, and 5 with
beta-ketothiolase deficiency); and 13 (6.1%) with
fatty acid oxidation disorders (including 1 with
carnitine palmitoyltransferase deficiency type I, 1 with
carnitine palmitoyltransferase deficiency type II, 1 with
short-chain acyl-CoA dehydrogenase deficiency, 5 with
medium-chain acyl-CoA dehydrogenase deficiency, 3 with
very long-chain acyl-CoA dehydrogenase deficiency, and 2 with
multiple acyl-CoA dehydrogenase deficiency). It is suggested that tandem mass spectrometry is useful for selective screening of clinically suspected patients. The majority of diseases (94%) in this study were
amino acid disorders and organic
acid disorders.
Fatty acid oxidation disorders are relatively rare in the Chinese, but
medium-chain acyl-CoA dehydrogenase deficiency should be further investigated.